相关实验视频
Updated: Jun 5, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
医生对指导方针的不同意是实现非常高风险患者LDL-C目标的关键障碍:一项实施科学研究
Kyung Hoon Cho1, Young Rak Cho2, Sang-Rok Lee3
1Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Journal of Korean medical science
|March 3, 2026
概括
医生对指导方针的不同意见阻碍了在高风险ASCVD患者中实现LDL-C目标. 不到60%的患者达到目标低密度脂蛋白胆固醇 (LDL-C) 水平,尽管治疗.
科学领域:
- 心脏病学 心脏病学
- 实施科学 实施科学
- 公共卫生 公共卫生
背景情况:
- 研究韩国医生在治疗动脉样硬化心血管疾病 (ASCVD) 患者时所面临的挑战.
- 专注于达到指导方针推的低密度脂蛋白胆固醇 (LDL-C) 水平,用于二次预防.
研究的目的:
- 确定在极高风险ASCVD患者中实现目标LDL-C水平的障碍.
- 分析影响降脂疗法强化的医生和患者因素.
主要方法:
- 展望实施科学研究 (2020-2022) 涉及704名非常高风险ASCVD患者.
- 基线LDL-C≥70 mg/dL在最大耐受度的他类药物和/或ezetimibe.
- 主要终点:达到LDL-C<70 mg/dL的比例;次要:指南采用因素.
主要成果:
- 在56.3% (第二次访问) 和58.7% (第三次访问) 达到LDL-C<70 mg/dL.
- 在55.7%的患者中,医生犹是否加强治疗 (仅使用他类药物) 和75.3%的患者 (他类药物+埃泽提米布).
- 不强化的主要原因:医生不同意指导方针 (70.8%和46.2%),患者拒绝,医疗限制和药物成本.
结论:
- 降脂疗法在极高风险ASCVD患者中,在不到60%的患者中实现了目标LDL-C.
- 医生与临床指导方针的分歧是推采用LDL-C降低疗法的主要障碍.
- 实施科学对于理解和克服ASCVD护理中遵循指南的挑战至关重要.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...